Search research articles
Contact Us
Filters
Showing results (71-80 of 77) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 77 results.
American Journal of Respiratory and Critical Care Medicine
|
March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial
Gerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
Circulation
|
June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension
D Langleben, R J Barst, D Badesch, et al.
Journal of the American College of Cardiology
|
March 30, 2002
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Ronald J Raymond, Alan L Hinderliter, Park W Willis, et al.
The American Journal of Cardiology
|
September 1, 1999
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension
A L Hinderliter, P W Willis, W Long, et al.
The American Journal of Cardiology
|
April 11, 2003
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
Alan L Hinderliter, Park W Willis, Walker A Long, et al.
The New England Journal of Medicine
|
February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
R J Barst, L J Rubin, W A Long, et al.
Circulation
|
March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group
A L Hinderliter, P W Willis, R J Barst, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 77) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 77 results.
American Journal of Respiratory and Critical Care Medicine
|
March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial
Gerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
Circulation
|
June 29, 1999
Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension
D Langleben, R J Barst, D Badesch, et al.
Journal of the American College of Cardiology
|
March 30, 2002
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
Ronald J Raymond, Alan L Hinderliter, Park W Willis, et al.
The American Journal of Cardiology
|
September 1, 1999
Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension
A L Hinderliter, P W Willis, W Long, et al.
The American Journal of Cardiology
|
April 11, 2003
Frequency and severity of tricuspid regurgitation determined by Doppler echocardiography in primary pulmonary hypertension
Alan L Hinderliter, Park W Willis, Walker A Long, et al.
The New England Journal of Medicine
|
February 1, 1996
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
R J Barst, L J Rubin, W A Long, et al.
Circulation
|
March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group
A L Hinderliter, P W Willis, R J Barst, et al.
Page
of 8